Allergies: Determinants of the polarisation of T2 lymphocytes and mechanisms of desensitisation;Allergies: Determinants de la polarisation Th2 et mecanismes de la desensibilisation

Revue des Maladies Respiratoires

Volumn 14, Issue 3, 1997, Pages 173-181

  Magnan, A ^a   Vervloet, D ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Allergy; Atopy; Desensitisation; T Cell; Th1 Th2

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

ALLERGY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; DESENSITIZATION; HELPER CELL; HLA SYSTEM; HUMAN; IMMUNOPATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; T LYMPHOCYTE SUBPOPULATION; ANIMAL; DISEASE MODEL; EOSINOPHIL; HYPERSENSITIVITY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METHODOLOGY; MOUSE; TH1 CELL; TH2 CELL;

ANIMALS; DESENSITIZATION, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; EOSINOPHILS; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-4; INTERLEUKIN-5; LYMPHOCYTE ACTIVATION; MICE; TH1 CELLS; TH2 CELLS;

EID: 0030837414     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. MOSSMAN TR, CHERWINSKI H, BOND MW, GIELDIN MA, COFFMAN RL : Two types of murine T cell clone. 1. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
2. PAUL WE, SEDER RA : Lymphocyte responses and cytokines. Cell 1994;76:241-51.
3. WINGHAGEN A, ANDERSON DE, CARRIZOSA A, WILLIAMS RE, HAFLER DA : IL-12 induces human T cells secreting IL-10 with IFN-γ. J Immunol 1996;157:1127-31.
4. ZHANG M, GATELY MK, WANG E et al : Interleukin 12 at the site of disease in tuberculosis. J Clin Invest 1994;93:1733-9.
5. ROBINSON DS, HAMID Q, YING S et al : Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298-304.
6. CORRIGAN C, HUMBERT M, DURHAM SR et al : Relationship of bronchial mucasal IL-5 mRNA expression with disease severity and IL-4 mRNA expression with serum IgE concentrations in atopic and non-atopic asthmatics. J Allergy Clin Immuno 1996;97:313 (abstract).
7. HAMID Q, BOGUNIEWICZ M, LEUNG DYM : Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 1994;94:870-6.
8. YING S, DURHAM SR, BARKANS J et al : T Cells are the principal source of interleukin-5mRNA in allergen-induced rhinitis. Am J Respir Cell Mol Biol 1993;9:356-60.
9. SCOTT P : IL12 : Initiation cytokine for cell-mediated immunity. Science 1993;260:496-7.
10. SEDER RA, GAZZINELLI R, SHER A, PAUL WE : Interleukin 12 acts directly on CD4+ T cells to enhance priming for Interferon γ production and diminishes interleukin-4 inhibition of such priming. Proc Natl Acad Sci USA 1993;90:10188-92.
11. KANG K, KUBIN M, COOPER KD, LESSIN SR, TRINCHIERI G, ROOK AH : IL-12 synthesis by human Langerhans cells. J Immunol 1996;156:1402-7.
12. HEINZEL FP, SCHOENHAUT DS, RERKO RM, ROSSER LE, GATELY MK : Recombinant IL-12 cures mice infected with Leishmania Major. J Exp Med 1993;77:1505-9.
13. GAVETT SH, O'HEARN DJ, LI X, HUANG SK, FINKELMAN FD, WILLS-KARP M : Interleukin-12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995;182:1527-36.
14. BRUSSELLE GG, KIPS JC, TAVERNIER JH et al : Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 1994;24:73-80.
15. CORRY DB, FOLKESSON HG, WARNOCK ML et al : Interleukin-4, but not Interleukin-5 or eosinophils, is required in a murine model of acute airway hypereactivity. J Exp Med 1996;183:109-17.
16. BRADDING P, FEATHER H, HOWARTH PH et al : Interleukin 4 is localized to and released by human mast cells. J Exp Med 1992;176:1381-6.
17. MOQBEL R, YING S, BARKANS J et al : Identification of messenger RNA for I1-4 in human eosinophils with granule localization and release of the translated product. J Immunol 1995;155:4939-47.
18. SAD S, MARCOTTE R, MOSSMAN T : Cytokine-induced differenciation of percursor mouse CD8+ T cells into CD8+ T cells secreting Th1 or Th2 cytokines. Immunity 1995;2:271-8.
19. RENZ H, LACK G, SALOGA J et al : Inhibition of IgE production and normalization of airways responsiveness by sensitized CD8 T cells in a mouse model of allergen-induced sensitization. J Immunol 1994;152:351-60.
20. MCMENAMIN C, PIMM C, MCKERSEY M, HOLT PG : Regulation of IgE responses to inhaled antigen in mice by antigen-specific γδ T cells. Science 1994;265:1869-71.
21. VICARI AP, ZLOTNIK A: Mouse NK1.1+ T cells: a new family of T cells. Immunol Today 1996;76:71-6.
22. TU YP, LARSEN GL, IRVIN CG : Utility of murine systems to study asthma pathogenesis. Eur Respir Rev 1995;5:224-30.
23. YOSHIMOTO T, BENDELAC A, HU-LI J, PAUL WE : Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin-4. Proc Natl Acad Sci USA 1995;92;11931-4.
24. GULER ML, GORHAM JD, HSIEH CS, MACKEY AJ, STEEN RG, DIETRICH WF, MURPHY KM : Genetic susceptibility to Leishmania : IL-12 responsiveness in Th1 development. Science 1996;271:984-7.
25. NOBEN-TRAUTH N, KROPF P, MULLER I : Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 1996;271:987-90.
26. WILKINSON J, HOLGATE ST : Candidate gene loci in asthmatic and allergic inflammation. Thorax 1996;51:3-8.
27. POSTMA DS, BLEECKER ER, AMELUNG PJ et al : Genetic susceptibility to asthma. Bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 1995;333:894-900.
28. SONG Z, CASOLARO V, CHEN R, GEORAS SN, MONOS D, ONO SJ : Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene. J Immunol 1996;156:424-9.
29. COOKSON WO : I1q and high-affinity IgE receptor in asthma and allergy. Clin Exp Allergy, 1995;25S2:71-3.
30. VAN HERWERDEN L, HARRAP SB et al : Linkage of high-affinity receptor gene with bronchial hyperreactivity, even in absence of atopy. Lancet 1995;346:1262-5.
31. MOFFATT MF, HILL MR, SCHOU CC et al : Genetic linkage of T-cell receptor alpha/delta complex to specific IgE responses. Lancet 1994;343:1597-600.
32. MARSH D, HSU HS, ROEBBER M ; HLA-Dw2 : a genetic marker for human immune response to short ragweed pollen antigen Ra5. I. Response resulting primarily from natural antigenic exposure. J Exp Med 1982;155:1439-41.
33. SOLOWAY P, FISH S, PASSMORE H, GEFTER M, COFFEE R, MANSER T : Regulation of the immune response to peptide antigens : Differential induction of immediate-type hypersensitivity and T cell proliferation due to changes in either peptide structure or major histocompatibility complex haplotype. J Exp Med 1991;174:847-58.
34. KUMAR V, BHARDWAJ V, SOARES L, ALEXANDER J, SETTE A, SERCARZ E : Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon Y by T cells. Proc Natl Acad Sci USA 1995;92:9510-4.
35. PFEIFFER C, STEIN J, SOUTHWOOD S, KETELAAR H, SETTE A, BOTTOMLY K : Altered peptide ligands can control CD4 T lymphocyte differenciation in vitro. J Exp Med 1995;181:1569-74.
36. EBNER C, SZÉPFALUSI Z, FERREIRA F et al : Identification of multiple T cell epitopes on Bet v1, the major birch pollen allergen, using specific T cell clones and overlapping peptides. J Immunol 1993;150.1047-54.
37. WIERENGA EA, SNOEK M, Bos JD, JANSEN HM, KAPSENBERG ML : Comparison of diversity and function of house dust mite-specific T lymphocyte clones from atopic and non-atopic donors. Eur J Immunol 1990;2:1519-26.
38. EBNER C, SCHENK S, NAJAFIAN N et al : Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients. J Immunol 1995;154:1932-40.
39. YSSEL H, JOHSON KE, SCHNEIDER PV et al : T cell activation-inducing epitopes of the house dust mite allergen Der p I. Proliferation and lymphokine production patterns by Der p I-specific CD4+ T cell clones. J Immunol 1992;148:738-45.
40. SLOAN-LANCASTER J, EVAVOLD BD, ALLEN PM : Th2 cell clonal anergy as a consequence of partial activation. J Exp Med 1994;180:1195-205.
41. SECRIST H, DEKRUYFF RH, UMETSU DT: Interleukin-4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J Exp Med 1995:181:1081-9.
42. HOSKEN NA, SHIBUYA K, HEATH AW, MURPHY KM, O'GARRA A : The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J Exp Med 1995;181:1579-84.
43. JüRGENS M, WOLLENBERG A, HANAU D, DE LA SALLE H, BIEBER T : Activation of human epidermal Langerhans cells by engagement of the high affinity receptor for IgE, FcεRI. J Immunol 1995;155:5184-9.
44. MAURER D, EBNER C, REININGER B et al : The high affinity IgE receptor (FcεRI) mediates IgE-dependent allergen presentation. J Immunol 1995;154:6285-90.
45. THOMPSON CB : Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differenciation. Cell 1995;81:979-82.
46. KUCHROO VK, DAS MP, BROWN JA et al : B7-1 and B7-2 costimulatory molecules activate differencially the Th1/Th2 developmental pathways : application to autoimmune disease therapy. Cell 1995;80:707-18.
47. BUNGRE J, TILL SJ, LARCHÉ M et al : IL-5 secretion by allergen-specific CD4+ cells in short term culture : dissociation from allergen-induced proliferation and dependence on B7-2 costimulation. J Allergy Clin Immunol 1996;97:359 (Abstract).
48. DEL PRETE G, DE CARLI M, D'ELIOS MM et al : CD30-mediated signaling promotes the development of human T helper type 2-like T cells. J Exp Med 1995;182:1655-61.
49. MURPHY E, SHIBUYA K, HOSKEN N et al : Reversibility of T helper 1 and T helper 2 populations is lost after long term stimulation. J Exp Med 1996, sous presse.
50. ABRAMSON MJ, PUY RM, WEINER JM . Is allergen immunotherapy effective is asthma ? A meta-analysis of randomized control trials. Am J Respir Crit Care Med 1995;151:969-74.
51. LICHTENSTEIN LM, HOLTZMAN NA, BURNETT LS : A quantitative in vitro study of the Chromatographic distribution and immunoglobulin characteristics of human blocking antibody. J Immunol 1968;101:317-24.
52. DAËRON M, MALBEC O, LATOUR S, AROCK M, FRIDMAN WH : Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest 1995;95:577-85.
53. TAKAI T, ONO M, HIKIDA M, OHMORI H, RAVETCH JV : Augmented humoral and anaphylactic responses in FcγRII-deficient mice. Nature 1996;379:346-9.
54. RAK S, LOWHAGEN O, VENGE P : The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. J Allergy Clin Immunol 1988;82:470-80.
55. NAGATA M, SHIBASAKI M, SAKAMOTO Y et al : Specific immunotherapy reduces the antigen-dependent production of eosinophil chemotactic activity from mononuclear cells in patients with atopic asthma. J Allergy Clin Immunol 1994;94:160-6.
56. O'HEHIR RE, YSSEL H, VERMA S, DE VRIES JE, SPITS H, LAMB JR : Clonal analysis of differential lymphokine production in peptide and superantigen induced T cell anergy. Int Immunol 1991;3:819-26.
57. SECRIST H, CHELEN CJ, WEN Y, MARSHALL JD, UMETSU DT : Allergen immunotherapy decreases interleukin-4 production in CD4+ T cells from allergic individuals. J Exp Med 1993;178:2123-30.
58. VARNEY VA, HAMID QA, GAGA M et al : Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 1993;92:644-51.
59. DURHAM SR, YING S, VARNEY VA et al : Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-γ. J Allergy Clin Immunol 1996;97:1356-65.
60. DURHAM SR, SCHOTMAN E, JACOBSON M, WALKER S, HAMID Q : Grass pollen immunotherapy : inhibition of allergeninduced late skin responses is associated with an increase in IL-12 messenger RNA+ cells. J Allergy Clin Immunol 1995;95:655 (abstract).
61. MGHUGH SM, DEIGHTON J, STEWART AG, LACHMANN PJ, EWAN PW : Bee venom immunotherapy induces a shift in cytokine responses from a Th2 to a Th1 dominant pattern : comparison of rush and conventional immunotherapy. Clin Exp Allergy 1995;25:828-38.
62. JUTEL M, PICHLER WJ, SKRBIC D, URWYLER A, DAHINDEN C, MULLER UR : Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T cell cultures. J Immunol 1995;154:4187-94.
63. AKOUM H, TSICOPOULOS A, VORNG H et al : Venom immunotherapy modulates interleukin-4 and interferon-γ messenger RNA expression of peripheral T lymphocytes. Immunology 1996;87:593-8.
64. NORMAN PS : Modern concepts of immunotherapy. Current Biology 1993;5:968-73.